ARTICLE | Company News
UCB sales and marketing update
March 7, 2016 8:00 AM UTC
UCB launched Briviact brivaracetam in the U.K. as an adjunct therapy to treat partial-onset seizures in epileptics ages 16 and older. The company said the high affinity synaptic vesicle protein (SV2...